| Dushyant Singh, | |
|
4801 College Blvd, Leawood, KS 66211-1628 | |
| (816) 478-4200 | |
| (816) 875-2597 |
| Full Name | Dushyant Singh |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 4801 College Blvd, Leawood, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598780660 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 04-35223 (Kansas) | Primary |
| Entity Name | Pratt Regional Medical Center Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578596904 PECOS PAC ID: 1355253238 Enrollment ID: O20040419001344 |
News Archive
"Most people focus on the dislike of the preparation, the need to arrange transportation and the fear of being anesthetized during the procedure and then potentially getting a cancer diagnosis," says Neil Gupta, MD, MPH, Director of Endoscopy at Loyola University Health System. "Screening colonoscopy is a very critical examination that really can determine life and death when it comes to colon cancer. It is now clear that not every colonoscopy is equal. Once you've decided it's time to get a screening colonoscopy, the next step is to make sure that you get a high-quality one."
A new research paper published in the Biophysical Journal describes a novel binding pocket used by a viral non-structural protein (nsp) to form an activated complex with its partner nsp. In so doing, it may have revealed a common target that may be useful in the development of a broad-spectrum antiviral drug against all coronaviruses.
Boehringer Ingelheim today announced that new data evaluating volasertib, an investigational polo-like kinase (Plk) inhibitor, will be presented at the 54th American Society of Hematology (ASH) annual meeting taking place December 8-11 in Atlanta, Ga.
New data from a meta-analysis of existing literature published today in CHEST, the official journal of the American College of Chest Physicians, demonstrate that Interferon Gamma Release Assays are superior to the previous standard in diagnostics, the 100+-year-old tuberculin skin test, for detecting confirmed active Tuberculosis disease.
Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells - outlining how cancer cells hijack specific pathways for uncontrolled proliferation - will lead to more efficient ways to fight it.
› Verified 3 days ago
| Entity Name | Dushyant Singh Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982312070 PECOS PAC ID: 1658740220 Enrollment ID: O20221205000943 |
News Archive
"Most people focus on the dislike of the preparation, the need to arrange transportation and the fear of being anesthetized during the procedure and then potentially getting a cancer diagnosis," says Neil Gupta, MD, MPH, Director of Endoscopy at Loyola University Health System. "Screening colonoscopy is a very critical examination that really can determine life and death when it comes to colon cancer. It is now clear that not every colonoscopy is equal. Once you've decided it's time to get a screening colonoscopy, the next step is to make sure that you get a high-quality one."
A new research paper published in the Biophysical Journal describes a novel binding pocket used by a viral non-structural protein (nsp) to form an activated complex with its partner nsp. In so doing, it may have revealed a common target that may be useful in the development of a broad-spectrum antiviral drug against all coronaviruses.
Boehringer Ingelheim today announced that new data evaluating volasertib, an investigational polo-like kinase (Plk) inhibitor, will be presented at the 54th American Society of Hematology (ASH) annual meeting taking place December 8-11 in Atlanta, Ga.
New data from a meta-analysis of existing literature published today in CHEST, the official journal of the American College of Chest Physicians, demonstrate that Interferon Gamma Release Assays are superior to the previous standard in diagnostics, the 100+-year-old tuberculin skin test, for detecting confirmed active Tuberculosis disease.
Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells - outlining how cancer cells hijack specific pathways for uncontrolled proliferation - will lead to more efficient ways to fight it.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dushyant Singh, 4801 College Blvd, Leawood, KS 66211-1628 Ph: (816) 478-4200 | Dushyant Singh, 4801 College Blvd, Leawood, KS 66211-1628 Ph: (816) 478-4200 |
News Archive
"Most people focus on the dislike of the preparation, the need to arrange transportation and the fear of being anesthetized during the procedure and then potentially getting a cancer diagnosis," says Neil Gupta, MD, MPH, Director of Endoscopy at Loyola University Health System. "Screening colonoscopy is a very critical examination that really can determine life and death when it comes to colon cancer. It is now clear that not every colonoscopy is equal. Once you've decided it's time to get a screening colonoscopy, the next step is to make sure that you get a high-quality one."
A new research paper published in the Biophysical Journal describes a novel binding pocket used by a viral non-structural protein (nsp) to form an activated complex with its partner nsp. In so doing, it may have revealed a common target that may be useful in the development of a broad-spectrum antiviral drug against all coronaviruses.
Boehringer Ingelheim today announced that new data evaluating volasertib, an investigational polo-like kinase (Plk) inhibitor, will be presented at the 54th American Society of Hematology (ASH) annual meeting taking place December 8-11 in Atlanta, Ga.
New data from a meta-analysis of existing literature published today in CHEST, the official journal of the American College of Chest Physicians, demonstrate that Interferon Gamma Release Assays are superior to the previous standard in diagnostics, the 100+-year-old tuberculin skin test, for detecting confirmed active Tuberculosis disease.
Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells - outlining how cancer cells hijack specific pathways for uncontrolled proliferation - will lead to more efficient ways to fight it.
› Verified 3 days ago
Dr. Robert Mark Ross, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 12823 Sagamore Rd, Leawood, KS 66209 Phone: 913-449-1721 Fax: 913-498-2358 | |
Dr. Shelley Lynn Alexander, D.O. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 10557 Mission Rd, Leawood, KS 66206 Phone: 913-213-6900 Fax: 913-213-6729 | |
Karl H Hanson Jr., M. D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 9703 Overbrook Rd, Leawood, KS 66206 Phone: 913-381-0548 | |
Yelena Pinzur, D.O. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 8800 State Line Rd, Leawood, KS 66206 Phone: 913-383-9099 Fax: 816-383-3103 | |
Stany A Dsilva, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 8800 State Line Rd, Leawood, KS 66206 Phone: 913-383-9099 Fax: 913-383-3103 | |
Marcus A. Neubauer, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 11805 Brookwood Ave, Leawood, KS 66211 Phone: 913-451-5620 | |
Laura Badjalimbe, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10977 Granada Ln Ste 105, Leawood, KS 66211 Phone: 816-822-0050 Fax: 816-447-3960 |